Total Funding
30
74
Total FundingGrant raised
Growth Score 30 in past quarter
-2 pts
Heat Score 74 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106459
NovoThelium is a biotechnology company developing a tissue-engineered nipple matrix for use in breast reconstruction.
- Lauren Cornell: CEO/Co-Founder
- Bianca Gonzales Cerqueira: Co-Founder
About the Company
NovoThelium is a biotechnology company developing a tissue-engineered nipple matrix for use in breast reconstruction. NovoThelium was founded in 2015 by biomedical engineers with family histories of breast cancer to work on nipple regeneration after mastectomy. NovoThelium is developing a bioengineered matrix that enables patients to regenerate a
nipple made from their own cells that maintains projection, has natural pigmentation, and improved sensation.
Women Founded
Women Led